Skip to main content
Erschienen in: Archives of Osteoporosis 1/2022

01.12.2022 | Original Article

Age-dependent assessment thresholds to optimize patient care in a resource-limited setting: an analysis based on the Sri Lankan FRAX model

verfasst von: Sarath Lekamwasam, Thilina Abeygunasekara, Nirmala Rathnayake, Gayani Liyanage, Sewwandi Subasinghe

Erschienen in: Archives of Osteoporosis | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract  

Summary

Age-dependent upper and lower assessment thresholds help categorizing women aged 40 years or more according to their fracture risk, independent of BMD information.

Introduction

Age-dependent assessment thresholds of the FRAX algorithm help stratifying men and women aged 40 years or more according to their fracture risk. This allows clinicians to decide on those who require interventions without BMD assessment and those who require BMD input for further assessment.

Methods

Intervention thresholds were defined by 10-year probabilities of a major osteoporotic fracture (MOF) and hip fracture (HF) considering a woman with a BMI of 25.0 kg/m2 having a prior fragility fracture but no other clinical risk factors. The lower assessment thresholds (LAT) were set at 0.8 times the 10-year probabilities of a MOF and HF in a woman with a BMI of 25.0 kg/m2, without previous fracture or other clinical risk factors. The upper assessment thresholds (UAT) were set at 1.2 times the intervention thresholds of MOF and HF. Fracture probabilities were estimated for the age range of 40–80 years, without BMD input. These values were applied to a group of women who underwent DXA for clinical reasons in a single center.

Results

The LATs of MOF and HF varied from 0.7 to 8.8% and 0.1 to 3.7%, from 40 to 80 years, respectively. The corresponding values for UATs were 2.5 to 21.6% and 0.3 to 8.4%. ITs of MOF and HF varied from 2.1 to 18% and 0.2 to 7%, respectively. When applied to a group of 315 postmenopausal women who underwent DXA for clinical indications, 22.9% of women were above the UATs (high-risk category) while 8.6% were below the LATs (low-risk category). The proportion of women in the intermediate category who require BMD for further assessment was 68.6% (95% CI 59.7 to 77.5%).

Conclusions

In nearly one-third of women aged 40 years or more, the decision to treat or not to treat can be achieved without BMD estimation. The remaining two-thirds will require a BMD assessment for further evaluation.
Literatur
1.
Zurück zum Zitat El-Hajj Fuleihan G, Chakhtoura M, Cauley JA, Chamoun N (2017) Worldwide fracture prediction. J Clin Densitom 20(3):397–424CrossRefPubMed El-Hajj Fuleihan G, Chakhtoura M, Cauley JA, Chamoun N (2017) Worldwide fracture prediction. J Clin Densitom 20(3):397–424CrossRefPubMed
2.
Zurück zum Zitat Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A (2008) Case finding for the management of osteoporosis with FRAX–assessment and intervention thresholds for the UK. Osteoporos Int 19(10):1395–1408CrossRefPubMed Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A (2008) Case finding for the management of osteoporosis with FRAX–assessment and intervention thresholds for the UK. Osteoporos Int 19(10):1395–1408CrossRefPubMed
3.
Zurück zum Zitat Johansson H, Kanis JA, Oden A, Johnell O, McCloskey E (209) BMD, clinical risk factors and their combination for hip fracture prevention. Osteoporos Int 20(10):1675–1682. Johansson H, Kanis JA, Oden A, Johnell O, McCloskey E (209) BMD, clinical risk factors and their combination for hip fracture prevention. Osteoporos Int 20(10):1675–1682.
4.
Zurück zum Zitat Claus-Hermberg H, Bagur A, Messina OD, Negri AL, Schurman L, Sánchez A (2009) FRAX: a new instrument for calculating 10-year absolute fracture risk. Medicina 69(5):571–575PubMed Claus-Hermberg H, Bagur A, Messina OD, Negri AL, Schurman L, Sánchez A (2009) FRAX: a new instrument for calculating 10-year absolute fracture risk. Medicina 69(5):571–575PubMed
5.
Zurück zum Zitat Kanis JA, Harvey NC, Cooper C, Johansson H, Odén A, McCloskey EV (2016) A systematic review of intervention thresholds based on FRAX : a report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos 11(1):25CrossRefPubMedPubMedCentral Kanis JA, Harvey NC, Cooper C, Johansson H, Odén A, McCloskey EV (2016) A systematic review of intervention thresholds based on FRAX : a report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos 11(1):25CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Kanis JA, Harvey NC, Johansson H, Odén A, Leslie WD, McCloskey EV (2915) FRAX and fracture prediction without bone mineral density. Climacteric 18 Suppl 2:2–9. Kanis JA, Harvey NC, Johansson H, Odén A, Leslie WD, McCloskey EV (2915) FRAX and fracture prediction without bone mineral density. Climacteric 18 Suppl 2:2–9.
7.
Zurück zum Zitat Kanis JA, McCloskey E, Johansson H, Oden A, Leslie WD (2012) FRAX(®) with and without bone mineral density. Calcif Tissue Int 90(1):1–13CrossRefPubMed Kanis JA, McCloskey E, Johansson H, Oden A, Leslie WD (2012) FRAX(®) with and without bone mineral density. Calcif Tissue Int 90(1):1–13CrossRefPubMed
8.
Zurück zum Zitat Compston J, Bowring C, Cooper A, Cooper C, Davies C, Francis R et al (2013) Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013. Maturitas 75(4):392–396CrossRefPubMed Compston J, Bowring C, Cooper A, Cooper C, Davies C, Francis R et al (2013) Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013. Maturitas 75(4):392–396CrossRefPubMed
9.
Zurück zum Zitat Lesnyak O, Zakroyeva A, Babalyan V, Cazac V, Gabdulina G, Ismailov S et al (2021) FRAX-based intervention thresholds in eight Eurasian countries: Armenia, Belarus, Georgia, Kazakhstan, the Kyrgyz Republic, Moldova, the Russian Federation, and Uzbekistan. Arch Osteoporos 16(1):87CrossRefPubMed Lesnyak O, Zakroyeva A, Babalyan V, Cazac V, Gabdulina G, Ismailov S et al (2021) FRAX-based intervention thresholds in eight Eurasian countries: Armenia, Belarus, Georgia, Kazakhstan, the Kyrgyz Republic, Moldova, the Russian Federation, and Uzbekistan. Arch Osteoporos 16(1):87CrossRefPubMed
10.
Zurück zum Zitat Nagendra L (2021) FRAX-based osteoporosis treatment guidelines for resource-poor settings in India. Int Urol Nephrol 16(1):69 Nagendra L (2021) FRAX-based osteoporosis treatment guidelines for resource-poor settings in India. Int Urol Nephrol 16(1):69
11.
Zurück zum Zitat Azagra R, Roca G, Martín-Sánchez JC, Casado E, Encabo G, Zwart M, et al (2015) FRAX® thresholds to identify people with high or low risk of osteoporotic fracture in Spanish female population. Med Clin 144(1):1–8. Azagra R, Roca G, Martín-Sánchez JC, Casado E, Encabo G, Zwart M, et al (2015) FRAX® thresholds to identify people with high or low risk of osteoporotic fracture in Spanish female population. Med Clin 144(1):1–8.
12.
Zurück zum Zitat Edwards FD, Grover ML, Cook CB, Chang YH (2014) Use of FRAX as a determinant for risk-based osteoporosis screening may decrease unnecessary testing while improving the odds of identifying treatment candidates. Women’s Health Issues 24(6):629–634CrossRefPubMed Edwards FD, Grover ML, Cook CB, Chang YH (2014) Use of FRAX as a determinant for risk-based osteoporosis screening may decrease unnecessary testing while improving the odds of identifying treatment candidates. Women’s Health Issues 24(6):629–634CrossRefPubMed
13.
Zurück zum Zitat Chandran M, McCloskey EV, Thu WPP, Logan S, Hao Y, Tay D et al (2018) FRAX® based intervention thresholds for management of osteoporosis in Singaporean women. Arch Osteoporos 13(1):130CrossRefPubMed Chandran M, McCloskey EV, Thu WPP, Logan S, Hao Y, Tay D et al (2018) FRAX® based intervention thresholds for management of osteoporosis in Singaporean women. Arch Osteoporos 13(1):130CrossRefPubMed
14.
Zurück zum Zitat Lekamwasam S, Chandran M, Subasinghe S (2019) Revised FRAX®-based intervention thresholds for the management of osteoporosis among postmenopausal women in Sri Lanka. Arch Osteoporos 14(1):33CrossRefPubMed Lekamwasam S, Chandran M, Subasinghe S (2019) Revised FRAX®-based intervention thresholds for the management of osteoporosis among postmenopausal women in Sri Lanka. Arch Osteoporos 14(1):33CrossRefPubMed
15.
Zurück zum Zitat Kyriakos G, Vidal-Casariego A, Quiles-Sánchez LV, Calleja-Fernández A, Ávila-Turcios D, Urosa-Maggi JA et al (2017) A comparative study between the implementation of the FRIDEX calibration and the NOGG guideline in the management of osteoporosis in routine clinical practice. Reumatol Clin 13(5):258–263CrossRefPubMed Kyriakos G, Vidal-Casariego A, Quiles-Sánchez LV, Calleja-Fernández A, Ávila-Turcios D, Urosa-Maggi JA et al (2017) A comparative study between the implementation of the FRIDEX calibration and the NOGG guideline in the management of osteoporosis in routine clinical practice. Reumatol Clin 13(5):258–263CrossRefPubMed
16.
Zurück zum Zitat Johansson H, Kanis JA, Oden A, Compston J, McCloskey E (2012) A comparison of case-finding strategies in the UK for the management of hip fractures. Osteoporos Int 23(3):907–915CrossRefPubMed Johansson H, Kanis JA, Oden A, Compston J, McCloskey E (2012) A comparison of case-finding strategies in the UK for the management of hip fractures. Osteoporos Int 23(3):907–915CrossRefPubMed
17.
Zurück zum Zitat Jhaveri S, Upashani T, Bhadauria J, Biswas S, Patel K (2015) Current clinical practice scenario of osteoporosis management in India. J Clin Diagn Res 9(10):Rc04–8. Jhaveri S, Upashani T, Bhadauria J, Biswas S, Patel K (2015) Current clinical practice scenario of osteoporosis management in India. J Clin Diagn Res 9(10):Rc04–8.
18.
Zurück zum Zitat Pickney CS, Arnason JA (2005) Correlation between patient recall of bone densitometry results and subsequent treatment adherence. Osteoporos Int 16(9):1156–1160CrossRefPubMed Pickney CS, Arnason JA (2005) Correlation between patient recall of bone densitometry results and subsequent treatment adherence. Osteoporos Int 16(9):1156–1160CrossRefPubMed
19.
Zurück zum Zitat Brask-Lindemann D, Cadarette SM, Eskildsen P, Abrahamsen B (2011) Osteoporosis pharmacotherapy following bone densitometry: importance of patient beliefs and understanding of DXA results. Osteoporos Int 22(5):1493–1501CrossRefPubMed Brask-Lindemann D, Cadarette SM, Eskildsen P, Abrahamsen B (2011) Osteoporosis pharmacotherapy following bone densitometry: importance of patient beliefs and understanding of DXA results. Osteoporos Int 22(5):1493–1501CrossRefPubMed
20.
Zurück zum Zitat Diez-Perez A, Adachi JD, Agnusdei D, Bilezikian JP, Compston JE, Cummings SR et al (2012) Treatment failure in osteoporosis. Osteoporos Int 23(12):2769–2774CrossRefPubMed Diez-Perez A, Adachi JD, Agnusdei D, Bilezikian JP, Compston JE, Cummings SR et al (2012) Treatment failure in osteoporosis. Osteoporos Int 23(12):2769–2774CrossRefPubMed
21.
Zurück zum Zitat Mithal A, Bansal B, Kyer CS, Ebeling P (2014) The Asia-Pacific Regional Audit-Epidemiology, Costs, and Burden of Osteoporosis in India 2013: A report of International Osteoporosis Foundation. Indian J Endocrinol Metab 18(4):449–454CrossRefPubMedPubMedCentral Mithal A, Bansal B, Kyer CS, Ebeling P (2014) The Asia-Pacific Regional Audit-Epidemiology, Costs, and Burden of Osteoporosis in India 2013: A report of International Osteoporosis Foundation. Indian J Endocrinol Metab 18(4):449–454CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Annonymous, (2019) World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions. Lancet Glob Health 7(10):e1332–e1345CrossRef Annonymous, (2019) World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions. Lancet Glob Health 7(10):e1332–e1345CrossRef
23.
Zurück zum Zitat Wali H, Hudani Z, Wali S, Mercer K, Grindrod K (2016) A systematic review of interventions to improve medication information for low health literate populations. Res Social Adm Pharm 12(6):830–864CrossRefPubMed Wali H, Hudani Z, Wali S, Mercer K, Grindrod K (2016) A systematic review of interventions to improve medication information for low health literate populations. Res Social Adm Pharm 12(6):830–864CrossRefPubMed
24.
Zurück zum Zitat Siris ES, Baim S, Nattiv A (2010) Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men. Postgrad Med 122(1):82–90CrossRefPubMed Siris ES, Baim S, Nattiv A (2010) Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men. Postgrad Med 122(1):82–90CrossRefPubMed
Metadaten
Titel
Age-dependent assessment thresholds to optimize patient care in a resource-limited setting: an analysis based on the Sri Lankan FRAX model
verfasst von
Sarath Lekamwasam
Thilina Abeygunasekara
Nirmala Rathnayake
Gayani Liyanage
Sewwandi Subasinghe
Publikationsdatum
01.12.2022
Verlag
Springer London
Erschienen in
Archives of Osteoporosis / Ausgabe 1/2022
Print ISSN: 1862-3522
Elektronische ISSN: 1862-3514
DOI
https://doi.org/10.1007/s11657-022-01118-5

Weitere Artikel der Ausgabe 1/2022

Archives of Osteoporosis 1/2022 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.